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The molecular role of corepressors is poorly under-
stood. Here, we studied the transcriptional function
of the corepressor SMRT during terminal adipogene-
sis. Genome-wide DNA-binding profiling revealed
that this corepressor is predominantly located in
active chromatin regions and that most distal
SMRT binding events are lost after differentiation
induction. Promoter-proximal tethering of SMRT in
preadipocytes is primarily mediated by KAISO
through the conserved TCTCGCGAGA motif. Further
characterization revealed that KAISO, similar to
SMRT, accelerates the cell cycle and increases fat
accumulation upon knockdown, identifying KAISO
as an adipogenic repressor that likely modulates
the mitotic clonal expansion phase of this process.
SMRT-bound promoter-distal sites tend to overlap
with C/EBPb-bound regions, which become occu-
pied by proadipogenic transcription factors after
SMRT clearance. This reveals a role for SMRT in
masking enhancers from proadipogenic factors in
preadipocytes. Finally, we identified SMRT as an
adipogenic gatekeeper as it directly fine-tunes tran-
scription of pro- and antiadipogenic genes.
INTRODUCTION
Our knowledge about the role and importance of transcriptional
corepressors is still in its infancy, despite the fact that several
have already been implicated in a wide range of biological
processes and diseases and that the majority yield develop-
mental defects or other severe phenotypes when deleted in
mice (Deplancke, 2009; Perissi et al., 2010). An interesting
example is the nuclear receptor corepressor 2 (NCoR2), also
known as silencing mediator of retinoic acid and thyroidhormone receptor (SMRT), which, among many other biological
processes, has been implicated in terminal white fat cell dif-
ferentiation (Perissi et al., 2010). For example, Yu et al. (2005)
demonstrated that SMRT knockdown (KD) causes increased
differentiation of 3T3-L1 preadipocytes as compared to control
cells (Figure S1), likely because of the upregulation of adipogenic
proteins, such as the master regulator PPARg. Recent in vivo
studies have confirmed the role of SMRT in adipogenesis,
demonstrating that heterozygous SMRT knockout mice (Sutanto
et al., 2010) or mice harboring targeted disruptions in the protein
interaction domain of SMRT (Fang et al., 2011) become super
obese and exhibit adipocyte hypertrophy when challenged
with a high-fat diet.
While the involvement of SMRT in adipogenesis is fairly well
established, the precise underlying molecular mechanism is
much less understood. Based on their observations, Yu et al.
(2005) proposed that in the absence of ligand, SMRT binds to
a nuclear receptor dimer consisting of RXRa and the master
regulator of terminal adipogenesis PPARg, and as such
represses the target genes of this dimer through its well-docu-
mented interaction with histone deacetylases (HDACs) (Feng
et al., 2011; Haberland et al., 2010; Perissi et al., 2010). When
ligand is present, SMRT dissociates from PPARg-RXRa, result-
ing in the activation of target genes and the induction of terminal
adipogenesis. Thus, given its association with HDACs and its
repressive function, SMRT was assumed to be predominantly
located in deacetylated genomic regions enriched for repressive
histone marks.
The lack of genome-wide DNA-binding profiling studies of
SMRT within this biological system or even large-scale core-
pressor analyses in general makes it difficult to validate this
hypothesis. We therefore set out to identify functional SMRT
antibodies as well as to optimize the ChIP protocol to allow
genome-wide ChIP coupled to high-throughput sequencing
(ChIP-Seq) of SMRT during terminal adipogenesis. For this
purpose, we used the mouse 3T3-L1 fibroblast cell line, given
its status as a well-accepted model system of terminal white
fat cell differentiation (Green and Kehinde, 1974; Rosen and
MacDougald, 2006). This is also reflected by the wealth ofMolecular Cell 46, 335–350, May 11, 2012 ª2012 Elsevier Inc. 335
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cells (Mikkelsen et al., 2010; Nielsen et al., 2008; Rosen and
MacDougald, 2006; Siersbæk et al., 2011), enabling us to exploit
the power of an integrative genomics approach to characterize
the molecular involvement of SMRT in terminal adipogenesis.
RESULTS
Genome-Wide DNA-Binding Profiling of SMRT during
Terminal Adipogenesis
We first assessed genome-wide SMRT DNA-binding in undiffer-
entiated 3T3-L1 cells (day 0 or D0), and initially identified >6,000
SMRT peaks. To evaluate the specificity of the SMRT antibody
and the accuracy of our peak detection approach, we compared
the ChIP-qPCR enrichment of several randomly selected peaks
as well as negative control genomic sites in SMRT and control
shRNA-treated 3T3-L1 cells (Figure S1). Fourteen out of the
fifteen tested regions showed a decrease in SMRT binding
(of which, 11 more than 2-fold), whereas no difference was
observed for negative control regions (Figure S2A), providing
confidence as to the specificity of the SMRT antibody as well
as to the accuracy of peak detection.
We then performed SMRT ChIP-Seq at four time points after
induction of differentiation, i.e., at 2 hr, day 1 (D1), day 4 (D4),
and day 6 (D6), to explore the dynamic behavior of SMRT binding
throughout terminal adipogenesis. These analyses revealed two
principal temporal patterns featuring respectively SMRT-bound
sites specific for D0 (2421) and those present at all-time points
(2270) (Figure 1A) (see Supplemental Experimental Procedures
for details, Table S1A for sequencing statistics, and Table S1B
for all identified SMRT peaks). We validated the observed
SMRT-DNA-binding dynamics by performing ChIP-qPCR on
randomly selected D0-specific SMRT peaks at D0 and D1 in
independent biological replicates. Out of 25 SMRT-bound
regions, 18 peaks (72%) showed a drop in enrichment at D1
(Figure S2B), supporting our genome-wide observation of
decreased SMRT binding after differentiation induction.
SMRT Exhibits Spatiotemporal DNA-Binding Properties
Further analysis of the D0-specific and all-time point peak
groups revealed a striking, nonrandom, time-dependent, and
bimodal pattern of DNA binding. Specifically, we found two
dominant locations for SMRT binding, respectively 100 bp
and 50 kb up- or downstream of the transcription start site
(TSS) with a clear demarcation of the proximal and distal binding
site groups (Figure 1B). The majority (70% versus 30%) of the
D0-specific SMRT target sites were located in distal (i.e., >1 kb
upstream/downstream of the TSS) as compared to proximal
(i.e., <1 kb upstream/downstream of the TSS) regions, in sharpFigure 1. Genome-wide Temporal Profiling of SMRT during Terminal A
Behavior
(A) Clustering of SMRT peaks at different time points of 3T3-L1 differentiation: p
(B) Histogram depicting the number of SMRT peaks with respect to their distanc
(C) Pie chart stratifying D0-specific and all-time point SMRT peaks with respect
(D) Representative UCSC browser snapshots demonstrating SMRT binding dy
represent significant SMRT peak calls as determined by the software QuEST. Pea
after library size adjustment.contrast to all-time point peaks, which showed a more balanced
(42% distal versus 58% proximal) SMRT-binding pattern
(Figure 1C). Interestingly, this spatial DNA-binding pattern delin-
eates distinct target gene functionalities: genes with proximal
SMRT peaks are predominantly involved in generic biological
processes, such as RNA metabolism, translation, transcription,
cell cycle, or oxidative phosphorylation, whereas distal peaks
were typically found around genes being involved in cell commu-
nication, cell structure andmotility, mesoderm development, cell
proliferation and differentiation, and ligand-mediated signaling
(Table S2A). In addition, we found a significant enrichment
(Q-value < 4.6E-15) among D0 SMRT targets for genes that are
differentially expressed during terminal adipogenesis as anno-
tated by the Molecular Signature Database (MSigDB, Table
S2B). Many of these also have a well-characterized function
in this differentiation process, including Pparg, Atf2, Prkab2
(Ampk1 catalytic activity regulating subunit), Rxra, Rxrb, Rara,
Bmp2k, Klf3, Klf6, Klf9, Med1, Ncoa4, etc. Representative
UCSC snapshots showing the dynamic binding pattern of
SMRT on important adipogenic genes are shown in Figure 1D.
De Novo Motif Analysis Identifies Several Putative
SMRT-Recruiting Factors
To better understand themolecular origin of this time-dependent
and bimodal DNA-binding behavior, we analyzed distal and
proximal SMRT DNA-binding sites for overrepresented motifs
at both temporal groups (D0-specific and all-time point peaks).
This analysis revealed a striking difference between motifs
enriched at distal versus proximal sites and between motifs
enriched at sites present in preadipocytes versus differentiating
adipocytes (Figure 2A), indicating that distinct sets of TFs are
likely responsible for mediating the spatiotemporal demarcation
of SMRT DNA-binding sites. We also studied the positional
distribution of motifs around the respective SMRT peak center,
as this can provide further detail as to whether SMRT may be
directly recruited to the DNA by the respective TFs or rather via
more complex, indirect interactions. For SMRT peaks containing
the TCTCGCGAGA, EBF1- or CTCF-associated motifs, we
observed exact motif positioning around the peak center (Fig-
ure S3A), indicative of direct SMRT recruitment, whereas the
othermotifs showed a bimodal (SP1, ZFP143/RBPJ), multimodal
(AP4, CWGSCWG), or broader distribution (GABPA, AP1; data
not shown).
PPARg and SMRT Exhibit Antagonistic Temporal
DNA-Binding Patterns during Terminal Adipogenesis
To further examine the molecular mechanisms underlying the
dynamic DNA-binding behavior of SMRT, we reanalyzed ChIP-
Seq data of PPARg (Nielsen et al., 2008), given its hypothesizeddipogenesis Reveals a Time-Dependent and Bimodal DNA-Binding
readipocyte or day 0 (D0), 2 hr, day 1 (D1), day 4 (D4), and day 6 (D6).
e to the nearest transcription start site.
to their distance to the nearest transcription start site.
namics at the adipogenic genes Ebf1, Pparg, Med1, and Sirt4. Black bars
k densities at respective time points of differentiation represent raw tag counts
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SMRT Regulates Adipogenesis via C/EBPb and KAISOimportance in tethering SMRT to the DNA (Yu et al., 2005). We
found that PPARg and SMRT follow opposite DNA-binding
dynamics, and have few overlapping binding regions. We also
tested whether SMRT may mark future PPARg sites in mature
adipocytes (D6), but we found little overlap between SMRT-
targeted regions and PPARg sites (5% or 480 out of 9090
peaks, Figure 2B), together suggesting that PPARg does not
play a major role in tethering SMRT to the DNA, at least in 3T3-
L1 cells. Importantly though, 33% (>1,100) of putative SMRT
target genes are eventually regulated by PPARg during adipo-
genesis, including well-characterized PPARg target genes
such as Cav1, Cav2, Plin4, and Acsl1, consistent with our obser-
vation that SMRT is targeting or marking critical adipogenic
genes.
Given the low overlap between PPARg and SMRT-marked
sites, we examined whether RXRa, the primary dimerization
partner of PPARg, is also absent from SMRT occupied regions.
We observed that only 15% (584) of all SMRT sites at D0 are
bound by RXRa. However, in contrast to PPARg, we found
that half (2273) of all SMRT sites are targeted by RXRa at
different days of adipogenesis (Figure 2B). These results
therefore suggest that SMRT targets many early adipogenic
regulatory sites that eventually become bound by RXRa as
either a homodimer or a heterodimer involving partners other
than PPARg.
SMRT Colocalizes with C/EBPb at Distal Regulatory
Sites during Early Adipogenesis
It is well established that the TF C/EBPb has a prominent role
during early adipogenesis (Rosen and MacDougald, 2006).
We therefore analyzed the relationship between SMRT and
C/EBPb using recently published C/EBPb ChIP-Seq data
(Siersbæk et al., 2011), revealing a marked colocalization down
to the level of peak maxima of C/EBPb- and SMRT-binding
events in preadipocytes, especially at distal (>60%) compared
to proximal (<15%) SMRT-bound sites (Figures 2C–2E and
Table S3A). We found that 1659 (89%) out of 1871 sites primed
by C/EBPb-SMRT in preadipocytes also showed stable or
recurring C/EBPb-binding during the first 2 days after differenti-
ation induction (Figure 2E). These results suggest a so far
unappreciated role for C/EBPb in mediating genome-wide
tethering of SMRT to promoter-distal sites in preadipocytes. In
addition, we observed that the majority of preadipocyte-marked
C/EBPb-SMRT sites are targeted by either C/EBPb (86%),Figure 2. De Novo Motifs and Integrative Genomics Analyses Identify
(A) Web logos of significantly enriched motifs predicted with MEME (see Supplem
values are indicated as well as the corresponding TFs if known.
(B) Pie charts depicting the colocalization dynamics of PPARg, RXRa, and PPAR
during terminal adipogenesis.
(C) SeqMINER-based clustering of all 4691 SMRT peaks sorted according to loca
enrichment (blue high and white low).
(D) Histogram depicting the distance between C/EBPb and SMRT peak maxima
(E) C/EBPb DNA-binding dynamics at proximal and distal SMRT peaks before (D
(F) Co-occupancy of C/EBPb and C/EBPd at proximal and distal SMRT sites in p
(G) Histogram depicting DNA-binding co-operativity of the early adipogenic TFs C
preadipocytes and bound by C/EBPb at 4 hr.
(H) Box plots depicting the DNA-binding dynamics of C/EBPb during three earl
compared to SMRT negative TF hotspots (right subpanel).C/EBPd (66%), STAT5a (29%), glucocorticoid receptor (27%),
or RXRa (20%) at 4 hr (Figures 2F and 2G), an early time point
at which most SMRT DNA-binding at the respective sites has
disappeared (Figure S3B). This observation is consistent with
the finding that C/EBPb acts as a pioneering TF by marking
so-called TF ‘‘hotspots’’ prior to differentiation induction (Sier-
sbæk et al., 2011). Interestingly, we found that SMRT-marked
TF hotspots show a 2.8-fold higher tag density of C/EBPb at
D0 as compared to TF hotspots which are not marked by
SMRT and, moreover, that the average tag density of C/EBPb
at SMRT-marked sites remains stable between D0 and 4 hr
(Figure 2H). We also observed that 40% (119/299) of TF hot-
spots, characterized by stable C/EBPb DNA-binding between
D0 and D2 (see Supplemental Experimental Procedures), are
marked by SMRT, as opposed to only 10% of hotspots tran-
siently induced at 4 hr (Table S3B). These results therefore
indicate that SMRT and C/EBPb together appear to mark regu-
latory sites in preadipocytes that are destined to become
populated by multiple proadipogenic TFs at an early phase of
terminal adipogenesis.
KAISO Targets SMRT to Promoter-Proximal
DNA-Binding Sites in Preadipocytes
The striking enrichment of the palindromic TCTCGCGAGA DNA
sequence in preadipocyte-specific promoter-proximal sites
(Figure 2A) as well as its position close to the TSS directly under-
neath SMRT peak maxima (Figures 3A and S3A) prompted us to
further characterize this putative DNA-binding site. This motif
was previously identified as one of the top ten most strongly
enriched and well-conserved motifs in human promoters (Xie
et al., 2005; Pique-Regi et al., 2011). To complement recent,
unfruitful efforts to deorphanize this motif (Mikula et al., 2010),
we scanned publicly available ENCODE TF ChIP-Seq data sets
for enriched DNA target sequences that resembled this motif.
Interestingly, data from one ChIP-Seq experiment targeting the
human BTB/POZ zinc finger TF KAISO in a lymphoblastoid cell
line revealed a near identical palindromic motif as the one
detected within SMRT peaks in the majority of human KAISO
sites (Figure 3B), suggesting that the highly conserved mouse
homolog of this TF, i.e., ZBTB33 or mouse KAISO, may mediate
SMRT targeting to mouse gene promoters. When studying
this palindromic site within human KAISO-bound regions in
more detail, we coarsely observed four different motif classes
with differential ChIP-Seq enrichment, including the full siteSeveral Putative SMRT-Recruiting Factors
ental Experimental Procedures). The occurrence frequencies and enrichment
g-RXRa peaks at all 2033 proximal and 2658 distal SMRT DNA-binding sites
l DNA-binding enrichment of C/EBPb in preadipocytes. Colors indicate C/EBPb
in preadipocytes.
0) and after differentiation induction (i.e., 2 hr, 4 hr, and D2).
readipocytes.
/EBPb, C/EBPd, GR, RXRa, and STAT5a at sites marked by SMRT-C/EBPb in
y adipogenic time points (D0, 2 hr, and 4 hr) at SMRT positive (left subpanel)
Molecular Cell 46, 335–350, May 11, 2012 ª2012 Elsevier Inc. 339
T
a
g
 c
o
u
n
t 
w
it
h
in
 S
M
R
T
 p
e
a
k
s
 (
D
0
)
BA
Preadipocyte-specific / promoter-proximal
Motif enrichment: 393/709 (55%)
Motif enrichment (all peaks): 752/1,253 (60%)
Motif enrichment (top 25% peaks): 251/313 (80%)
SMRT ChIP-SeqHuman KAISO ChIP-Seq
1000 500 0 500 1000
Distance to nearest TSS (bp)
D
e
n
s
it
y
0.005
0.004
0.003
0.002
0.001
0
C
TCTCGCGAGA TCTCGCG CGCGAGA Degenerate motif
0
50
100
150
200
D
TCTCGCGAGA TCTCGCG CGCGAGA Degenerate motif
0
500
1000
1500
2000
2500
3000
SMRT ChIP-SeqHuman KAISO ChIP-Seq
P
e
a
k
 e
n
ri
c
h
m
e
n
t
E
F
Human KAISO ChIP-Seq
SMRT ChIP-Seq
HNRNPK RMI1
Hnrnpk Rmi1
D0
2h
D1
D4
D6
G
KAISO eGFP
DNA free
DNA bound
KAISO eGFP
DNA free
DNA bound
TCT  CG  CGAGA
TCTCGCGAGA
+-
R
e
la
ti
v
e
 a
ff
in
it
y
 (
a
.u
.)
0
20
40
60
80
100
TCTCGCGAGA
-
AGACGCGTCTKBSControl
- -CpG methylation +
m m
DNA
DNA
H
D0
SMRT
KAISO
KAISO ChIP (D0)I
%
 i
n
p
u
t 
e
n
ri
c
h
m
e
n
t
SMRT (+) KAISO (+)
promoter-proximal
SMRT (+) KAISO (-)
promotor-proximal
SMRT (+) KAISO (-)
promoter-distal
J H3K9me2 ChIP (D0)
0
0.5
1
1.5
2
2.5
%
 i
n
p
u
t 
e
n
ri
c
h
m
e
n
t
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
SMRT (+) KAISO (+)
promoter-proximal
SMRT (+) KAISO (-)
promotor-proximal
SMRT (+) KAISO (-)
promoter-distal
D6
Figure 3. KAISO Targets SMRT to Promoter-Proximal DNA-Binding Sites in Preadipocytes
(A) Histogram depicting the distance of KAISO motifs, enriched in D0-specific promoter-proximal SMRT peaks, to the nearest transcription start site (TSS).
(B) Comparison between the orphan TCTCGCGAGA motif enriched in D0-specific promoter-proximal SMRT peaks and a motif derived from the top 25%
high-confidence peaks in human KAISO ChIP-Seq data.
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and degenerate sites harboring either mutations in the core
CGCG sequence or in both flanking sequences (Figure 3C and
Table S4A).
Based on the latter observation, we expect strongest binding
of mouse KAISO to regions containing the full motif, and we
therefore may expect strongest binding of SMRT to these
regions as well if, as we hypothesize, KAISO mediates SMRT
DNA-binding. We found that SMRT peaks containing the full
motif had indeed 1.5- and 2.5-fold more reads as compared
to, respectively, the two half or degenerate motif-containing
peaks (p < 1E-4, Mann-Whitney U test; Figure 3D). In addition,
we observed that human syntenic regions of mouse SMRT-
binding sites have a high likelihood of also having a KAISO
peak containing either a palindromic or half motif site, consistent
with the reported conserved nature of this motif (Xie et al., 2005)
(Figures 3E and 3F).
To examine the relevance of the palindromic site in KAISO
DNA binding, we used a microfluidics-based protein-DNA inter-
action detection technology, MITOMI (Maerkl and Quake, 2007),
to study the relative DNA-binding affinity of mouse KAISO for the
detected sites as well as for the previously reported KAISO-
binding sequence or KBS (TCCTGCNA; Daniel et al., 2002).
We thereby also examined the DNA-binding capacity of this TF
to amethylated version of the palindromicmotif (TCTCGCGAGA)
given the previously reported ability of human KAISO to bind to
methylated CpG dinucleotides (Daniel et al., 2002; Yoon et al.,
2003). We observed highest relative affinity to the methylated
palindromic site, whereas the affinities for the unmethylated
palindromic site were near background (i.e., negative control)
(Figures 3G and S3C), thus providing direct evidence that the
conserved orphan motif TCTCGCGAGA is bound by KAISO.
Importantly, swapping the flanking sites around the methylated
core motif CGCG clearly reduced the relative affinity, suggesting
that, while DNA methylation is critical, the flanking sequences
play an important role. We also observed binding to the KBS,
revealing a higher affinity for this site than the core methylated
CGCGmotif. However, KAISO possesses an even higher affinity
for the methylated palindromic motif than the KBS, indicating,
together with the ChIP-Seq data, that the former site may be
the principal binding motif.(C) ChIP-Seq enrichment at KAISO peaks with full (TCTCGCGAGA), half (TCTCG
(D) Number of reads at SMRT peaks in preadipocytes with full (TCTCGCGAGA),
(E) Browser snapshot showing the position of a KAISO peak near the TSS of the
(F) Browser snapshot showing the position of a SMRT peak near the TSS of the
(G) The left panel shows raw MITOMI data revealing the extent of KAISO-eGFP
methylated TCTCGCGAGA motif (bottom). The right panel shows the relative affi
KAISO binding site (KBS) (TCCTGCCA; Daniel et al. [2002]), to the methylated
unmethylated core CGCG motif. Relative affinities are expressed in arbitrary un
palindromic motif (‘‘100’’ value, see also Supplemental Experimental Procedu
experiments.
(H) SDS-PAGE followed by western blotting for SMRT or KAISO proteins in S
a representative blot of three replicate experiments.
(I) KAISO ChIP-qPCR at SMRT-bound promoter-proximal regions containing a
proximal and promoter-distal regions lacking a discernible KAISOmotif (KAISO [–
(J) ChIP-qPCR enrichment analysis of the H3K9me2 histone modification mark in
Ctl2 are control regions selected because they are positive for H3K27me3 in prea
from three replicate experiments.Yoon et al. (2003) have previously shown that human KAISO
can interact with the SMRT homolog NCoR1 in HeLa cells,
suggesting that mouse KAISO may be able to bind to SMRT as
well. As shown in Figure 3H, pull-down of SMRT revealed the
presence of KAISO, indicating that SMRT and KAISO are
components of the same protein complex as also observed for
KAISO and NCoR1 in mouse cells (Figure S3E). Moreover, we
detected less KAISO after a SMRT IP in a SMRT KD versus an
NCoR1 or control (empty vector) context, lending support to
the specificity of the uncovered interaction (Figure S3F). To
confirm that KAISO is most likely tethering SMRT to DNA in
3T3-L1 cells, we employed SMRT ChIP-qPCR on 12 randomly
selected KAISO motif-containing promoters in KAISO KD
preadipocytes (Figure S3G) and compared the results against
SMRT ChIP-qPCR enrichments in shRNA control and SMRT
KD cells, respectively. These analyses revealed a decrease in
SMRT enrichment in KAISO KD compared to control cells at all
12 promoters, similar to the decrease observed in SMRT KD
cells. To further validate the involvement of KAISO in the binding
of SMRT to the DNA, we performed KAISO ChIP-qPCR, using
two different antibodies on 15 sites predicted to be bound by
KAISO at D0, and found that 14 out of 15 analyzed regions are
occupied by KAISO (Figures 3I and S3H). In contrast, none out
of 15 SMRT-bound regions without a predicted KAISO motif
and none out of two negative control regions were bound.
Thus, our results strongly support the notion that KAISO is an
important mediator of SMRT DNA-binding to promoter-proximal
sites.
KAISO and SMRT Are Located in Semiaccessible
and Active Chromatin Regions
Both KAISO and SMRT have been described as transcriptional
repressors (Daniel and Reynolds, 1999; Perissi et al., 2010).
Consistent with this observation is the detection of KAISO in
a DNA region enriched for the repressive H3K9me2 mark
(Yoon et al., 2003). However, ChIP-qPCR for H3K9me2 on 14
sites positive for KAISO binding in preadipocytes (Figure 3I)
revealed that these DNA regions are not enriched for this mark,
as opposed to other non-KAISO-bound regions (Figure 3J). For
SMRT, it has been proposed that its repressive function is
mediated by its interaction with HDACs, which establish a local,CG or CGCGAGA), or degenerate KAISO motifs.
half (TCTCGCG or CGCGAGA), or degenerate KAISO motifs.
human HNRNPK gene based on human KAISO ChIP-Seq data.
mouse Hnrnpk gene.
binding (i.e., ‘‘DNA bound’’) to the methylated (top) as compared to the non-
nity of KAISO to an unmethylated control sequence, to the previously reported
and unmethylated palindromic TCTCGCGAGA motif, and to a methylated or
its (a.u.) and scaled based on the extent of KAISO binding to the methylated
res). Error bars represent the standard deviation of three replicate MITOMI
MRT antibody immunoprecipitated samples. The presented data constitute
predicted KAISO motif (KAISO [+]) as compared to SMRT-bound promoter-
]). Error bars represent the standard deviation from three replicate experiments.
SMRT-bound regions with (+) or without (–) a predicted KAISO motif. Ctl1 and
dipocytes (Mikkelsen et al., 2010). Error bars represent the standard deviation
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SMRT Regulates Adipogenesis via C/EBPb and KAISOrepressed chromatin state, as indicated above. However, to our
surprise, we found that SMRT is predominantly located within
seemingly open and active chromatin regions based on DHS,
H3K27ac, H3K4me1, H3K4me3, and H3K27me3 data (Figures
4A–4E and S4A–S4E). Interestingly, however, when examining
the change in chromatin ‘‘accessibility’’ (as determined by the
peak height of DHS regions) of SMRT-bound sites before and
after differentiation induction, we found a general rise in the
extent of chromatin accessibility, especially after 2 hr, suggest-
ing that a loss of SMRT binding correlates with an increased
accessibility of these sites (Figure S5A). A similar trend was
observed when only KAISO motif-containing SMRT-binding
sites were considered (Figure S5B). A representative summary
of all the observed SMRT DNA-binding properties can be
observed at the Tle3 gene locus (Figure 4F).
Preadipocyte-Specific SMRT-Bound Genes Show
Increased Gene Promoter and Gene Body RNA
Polymerase II Tag Density after Differentiation
Induction
To explore the significance of these findings with respect to
transcription, we integrated our SMRT peak with ChIP-Seq
data representing the genome-wide mapping of RNA pol II
over the course of 3T3-L1 terminal differentiation (Nielsen
et al., 2008). These analyses revealed that RNA pol II occupancy
on the promoters of SMRT target genes is significantly greater
than that of other genes, indicating that SMRT primarily associ-
ates with transcriptionally active or at least primed genes,
consistent with the histone modification and DHS data (Fig-
ure S6). Interestingly, we also found that the median promoter
occupancy of genes with proximal SMRT peaks at D0 is almost
double that of genes featuring only distal peaks in contrast to
gene body RNA pol II occupancy, which is similar for both
categories (Figures 5A–5D and S6). This result may be reflective
of increased RNA pol II pausing at the promoters of genes with
proximal SMRT sites. Finally, we observed that preadipocyte-
specific SMRT target genes typically exhibited increased RNA
pol II binding at both their promoters and gene bodies after
differentiation induction, in contrast to their all-time point coun-
terparts (Figures 5E–5H). Thus, genes with continuous SMRT
binding tend to remain in a silenced or at least more repressed
state, consistent with the repressive properties of SMRT.
KAISO Is a Repressor of Terminal Adipogenesis Likely
by Controlling the Mitotic Clonal Expansion
of Preadipocytes through SMRT
D0-specific SMRT peaks that are located close to promoters are
significantly enriched for the KAISO motif (i.e., 393 out of 709
sites). Thus, we specifically determined whether genes with
promoter-proximal SMRT sites containing a KAISO motif could
be responsible for the observed RNA pol II-based transcriptional
activity pattern when considering all proximal SMRT sites. For
this purpose, we plotted promoter versus gene body RNA pol
II occupancy, revealing a striking dynamic relationship between
these two parameters (Figure 5I). Specifically, we found that
the promoters of SMRT/KAISO-positive genes exhibit high
RNA pol II occupancy at D0 in contrast to their respective gene
bodies and that loss of SMRT (D1) correlates with an important342 Molecular Cell 46, 335–350, May 11, 2012 ª2012 Elsevier Inc.RNA pol II occupancy increase at the promoters and especially
in gene bodies. This trend is reversed at D3–4 to the point where,
at D6, respective RNA pol II occupancy values are lower than
those at D0 for both gene promoters and bodies, indicating
that many genes may have entered a transcriptionally silent
state. We also performed a similar analysis for SMRT peaks
containing the ZFP143/RBPJ motif, which is enriched in all-
time point proximal SMRT sites, and observed low promoter
and gene body RNA pol II occupancy throughout differentiation
(Figure 5J), indicating that all-time proximal SMRT peaks tend to
be associatedwith transcriptionally silent genes. Together, these
results suggest that SMRT controls the transcriptional activity of
genes by mediating RNA pol II pausing and release through
KAISO.
As indicated earlier, the list of proximal SMRT targets is signif-
icantly enriched for genes involved in cell cycle, transcription,
and translation. As expected, a similar observation was made
for SMRT/KAISO targets (Tables S4B and S4C). Together with
their transcriptional upregulation after differentiation induction,
this prompted us to speculate that genes targeted by SMRT/
KAISO may mediate the mitotic clonal expansion (MCE) phase
of terminal adipogenesis, during which growth-arrested cells
re-enter the cell cycle and undergo at least one round of clonal
expansion as a prerequisite to express adipogenic proteins
and thus to generate terminally differentiated cells (Tang et al.,
2003). To test this hypothesis, we profiled the cell cycle in
SMRT KD and shRNA control cells during the first 24 hr of
terminal differentiation. The underlying reasoning is that the
absence of SMRT may accelerate the expression of critical
MCE genes and hence prime the cells for a faster cell-cycle
progression upon exposure to differentiation medium. Using
propidium iodide-based FACS, we observed that SMRT KD
cells reached the G2/M phase significantly faster than control
cells (Figures 6A–6E), suggesting that SMRT indeed plays a
role in cell-cycle control. Finally, we tested whether KAISO KD
would have similar phenotypic consequences to SMRT KD
with respect to the cell cycle and the ability to differentiate.
This may be expected if SMRT and KAISO indeed functionally
interact. As shown in Figures S7A–S7E, KAISO KD accelerates
the cell cycle and enhances fat cell differentiation as compared
to control cells (Figure 7A). Thus, these findings suggest that
KAISO is a repressor of terminal adipogenesis, likely by control-
ling the initial MCE phase during terminal adipogenesis through
SMRT.
SMRT Is a Gatekeeper of Terminal Adipocyte
Differentiation
To further explore the transcriptional function of SMRT in
terminal adipogenesis, we used RNA pol II ChIP-Seq to specifi-
cally investigate the genome-wide effect of SMRT KD on gene
transcription in preadipocytes. We identified 417 genes that
are differentially transcribed between SMRT KD and shRNA
control cells (fold-change > 1.5 and FDR < 1%; see Table S5A
for all differentially transcribed genes). We also examined
whether these transcriptional changes were apparent at the
expression (mRNA) level and based on 29 tested genes, the
vast majority (79%) were found to exhibit a similar differential
expression trend (Table S5B). The majority (234 or 59%) of the
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Figure 4. Chromatin Regions Bound by SMRT are Semiaccessible and Contain Active Chromatin Marks
(A) Correlation of SMRT-bound regions with DNase I hypersensitive sites (DHSs) during terminal adipogenesis.
(B–E) Enrichment of the H3K27ac (B), H3K27me3 (C), H3K4me3 (D), and H3K4me1 (E) histone modification marks in SMRT-bound DNA regions.
(F) Overview of SMRT DNA-binding properties as illustrated by its binding pattern and overlap with histone modification marks, DHSs, C/EBPb, and C/EBPd-
binding sites at the Tle3 gene locus.
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Figure 6. SMRT KDCells Exhibit Accelerated Cell Cycle Progression during the Early Mitotic Clonal Expansion Phase of Terminal Adipogen-
esis
(A–B) Propidium iodide (PI) staining-based FACS analysis of SMRT KD (A) and shRNA control (B) cells 3 days before and during the first 24 hr after differentiation
induction.
(C–E) Histograms indicating the percentage of SMRT KD and shRNA control cells at each cell-cycle phase (G0/G1, S, and G2/M) during the first 24 hr after
differentiation induction (**p < 0.01, *p < 0.05; t test). Error bars show the standard error of the mean from three replicate experiments.
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SMRT Regulates Adipogenesis via C/EBPb and KAISOdifferentially transcribed genes were upregulated, consistent
with the role of SMRT as a corepressor. Importantly, 71 (30%)
of these 234 genes were direct SMRT targets, which represents
a significant enrichment over randomly selected genes (p <
0.01). Nevertheless, the transcriptional activity of the majority
of SMRT target genes was not altered upon SMRT KD (Fig-
ure 7B). While a similar effect (or lack thereof) has been observed
for many TFs (Farnham, 2009), one explanation could be that this
may be due to compensatory mechanisms by the SMRT
homolog NCoR1. To investigate this, we determined the DNA-
binding profiles of NCoR1 pre (D0)- and post (D4)-differentiation.Figure 5. Transcriptional Dynamics of SMRT Target Genes
(A–H) RNA pol II occupancy at the promoters (30 to 300 bp relative to TSS) and b
course of terminal adipogenesis.
(I–J) Transcriptional dynamics of genes with promoter-proximal SMRT peaks c
adipogenesis. Colors indicate the density of genes (red low and pink high).As displayed in Figure 7C, we found that around two thirds of all
SMRT-bound regions are also enriched for NCoR1 at D0, indi-
cating that the DNA-binding profiles of these two corepressors
largely overlap. In addition, overall DNA-binding enrichment of
NCoR1 pre- and postdifferentiation decreased, together sug-
gesting that, similar to SMRT, DNA-binding in preadipocytes is
an important functional property of NCoR1 and that SMRT and
NCoR1 may act cooperatively to control transcription.
Of note, several of the upregulated genes in SMRTKD cells are
involved in terminal adipogenesis such as C/ebpa, Ebf1, Stard4,
Plin4, and Pparg2. The upregulation of bothC/ebpa and Pparg2,odies of D0-specific (A–D) and all-time point (E–H) SMRT-bound genes over the
ontaining KAISO (I) or ZNF143/RBPJ (J) motifs over the course of terminal
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SMRT Regulates Adipogenesis via C/EBPb and KAISOwhich is also apparent at the mRNA and protein levels (Figures
7D and 7E), is of major interest given their status as master
regulators of terminal adipogenesis. This is, however, not suffi-
cient to trigger terminal adipogenesis, as SMRT KD cells do
not spontaneously differentiate, suggesting that PPARg2 may
not be transcriptionally active. To test this, we exposed SMRT
KD preadipocytes to rosiglitazone, a synthetic PPARg ligand
and activator, and monitored the extent of differentiation. As
shown in Figures 7F and 7G, the addition of this ligand, but not
of either insulin or dexamethasone, was sufficient to induce
differentiation in SMRT KD but not in shRNA control cells, indi-
cating that, as suggested above, SMRT KD cells are primed for
differentiation, but require a critical activating signal to pass
a differentiation threshold.
DISCUSSION
This study used an integrative genomics approach to uncover
several findings regarding how SMRT may transcriptionally
control terminal adipogenesis. First, we found that SMRT
exhibits a time-dependent, bimodal pattern of DNA binding,
which may be directly mediated by KAISO and C/EBPb. This is
because we (this study) and others (Rosen and MacDougald,
2006) have shown that both TFs affect the terminal differentiation
process. In addition, these TFs are linked to the majority of
respectively proximal and distal SMRT DNA-binding sites, and
their binding motifs (TCTCGCGAGA for KAISO) or peaks (C/
EBPb) are highly enriched at SMRT peak maxima, suggestive
of direct interactions. The latter observation is supported by
our (KAISO) as well as other published protein interaction data
(C/EBPb; Ki et al. [2005]), even though further biochemical
experiments will be required to elucidate the precise molecular
context of these interactions. In contrast to KAISO, which is
widely known as a transcriptional repressor (Daniel and Rey-
nolds, 1999), the association between C/EBPb and SMRT is
not very intuitive, given that this TF has been shown to promote
terminal adipogenesis by directly inducing the adipogenic
master regulators PPARg and C/EBPa (Rosen andMacDougald,
2006). This suggests that C/EBPb either acts by itself as an acti-
vator or acts within an activating and not a repressing complex.Figure 7. KAISO KD Enhances Fat Cell Differentiation, NCoR1 and SM
Preadipocytes Exhibit Increased Expression of Adipogenic Genes and
(A) Oil red O staining of shRNA control and KAISOKD cells after 6 days of differenti
experiments.
(B) Dot plot showing differential changes in RNA pol II transcription of annotated
D0. Red dots show transcripts with significant differential transcription between
Procedures for more details). Blue circles indicate differentially transcribed trans
known to be involved in terminal adipogenesis are highlighted.
(C) NCoR1 ChIP-Seq enrichment at all 4691 SMRT sites in preadipocytes (D0) a
clustering.
(D) Fold-change in mRNA levels of adipogenic genes in SMRT KD versus shRNA
Error bars depict the standard error of the mean from three replicate experiment
(E) Changes in SMRT, PPARg, and C/EBPa nuclear protein levels in SMRT KD and
SDS-PAGE followed by western blotting. The data shown are representative of
additional Ponceau S staining confirmed equal sample amount loading (data not
(F and G) Oil red O staining of shRNA control and SMRT KD cells at D6 cultured
entiation medium; well3, 100 nM rosiglitazone; well4, 250 nM rosiglitazone; well5
a representative result of three replicate experiments.In addition, it has long been believed that C/EBPb DNA binding
only occurs after differentiation induction. However, recent
genome-wide DNA-binding profiling of this TF demonstrated
substantial DNA-binding activity in preadipocytes, challenging
this earlier view (Siersbæk et al., 2011). Together with the exten-
sive overlap between C/EBPb- and SMRT-bound regions and
with our observation that many of these regions are targeted
by early adipogenic TFs within 2–4 hr of differentiation induction
accompanied by an increased accessibility of the surrounding
chromatin, these findings suggest a model in which SMRT func-
tions to block the adipogenic regulatory potential of C/EBPb in
preadipocytes until the appropriate differentiation stimuli are
present. SMRT may do so by restraining the accessibility of
C/EBPb-bound sites through its interaction with HDACs, thereby
preventing the binding of early activating TFs (e.g., GR or RXRa)
and the subsequent recruitment of a coactivator complex.
Indeed, docking of GR along with other activating TFs to
C/EBPb-bound distal regions has previously been shown to
result in recruitment of a coactivator complex leading to activa-
tion of adipogenic genes such as PPARg (Steger et al., 2010).
Moreover, about two thirds of all SMRT-C/EBPb-bound sites in
preadipocytes were classified as D0-specific, indicating that
the inverse correlation between SMRT binding and early proadi-
pogenic TF recruitment appears to be an important regulatory
aspect of terminal adipogenesis (Figure S8).
A second major finding is that, in contrast to what was so far
predicted (Rosenfeld et al., 2006; Yu et al., 2005), SMRT is
predominantly tethered to DNA regions enriched for active
histone marks. In addition, many SMRT-bound promoters also
exhibited relatively high RNA pol II occupancy levels, reflective
of primed gene transcription. These findings are however consis-
tent with recent work demonstrating that the promoters of
several genes activated by lipopolysaccharide through Toll-like
Receptor 4 signaling tend to be occupied by both stalled RNA
pol II and the SMRT homolog NCoR1 under basal conditions in
macrophages (Hargreaves et al., 2009). Interestingly, several of
these LPS-responsive genes were previously shown to exhibit
de-repression in macrophages lacking NCoR1 (Ogawa et al.,
2004). Thus, these findings suggest a possible link between
NCoR1 and RNA pol II stalling and imply that active removal ofRT DNA-Binding Profiles Overlap to a Large Extent, and SMRT KD
Differentiate upon Exposure to the PPARg Ligand Rosiglitazone
ation. The presented images constitute a representative result of three replicate
transcripts in SMRT KD as compared to control shRNA treated 3T3-L1 cells at
both cell lines (FDR < 1%; fold-change > 1.5; see Supplemental Experimental
cripts annotated as putative SMRT targets (Table S1B). Several marker genes
nd after differentiation induction (D4). Peaks are sorted based on SeqMINER
control cells over the course of terminal adipogenesis as measured by qPCR.
s.
shRNA control cells over the course of terminal adipogenesis as determined by
three replicate experiments. PCNA is used as the loading control. Note that
shown).
in distinct differentiation media: well1, uninduced cells; well2, normal differ-
, 167 nM insulin; well 6, 1 mM dexamethasone. The presented data constitute
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II release and hence gene activation as recently proposed (Glass
and Saijo, 2010). Here, we provide evidence on a genome-wide
level that SMRT may function in similar fashion during terminal
adipogenesis, in that we found that SMRT tends to be associ-
ated with genes with high RNA pol II promoter, but low gene
body, occupancy and that loss of SMRT correlates with RNA
pol II release. This trend was most prominent for proximal
SMRT peaks, particularly those containing KAISO-binding sites.
Together with the increasing recognition that proximal binding
complexes may regulate transcription by directly interacting or
stabilizing general TFs (Farnham, 2009), our findings suggest
that SMRT may have a much more active role in controlling
transcriptional dynamics than is currently appreciated.
A third major finding is the observation that both KAISO and
SMRT have an impact on the cell cycle and that they as such
may control theMCE phase of terminal adipogenesis (Figure S8).
For KAISO, this is consistent with a recent study demonstrating
accelerated cell proliferation in human cells in which KAISO is
depleted (Soubry et al., 2010). A role for SMRT in the cell cycle
has also been suggested in a recent study by Bhaskara and
colleagues (2010) who, based on their findings, even speculated
that this may be an ancestral function of this corepressor, which
later evolved to mediate cell-cycle-dependent gene expression
in a cell-type-specific fashion. The specific involvement of
SMRT (NCoRs) in cell-cycle-related processes is rather ambig-
uous at this point, though, as both enhancing or attenuating
effects have been observed (Battaglia et al., 2010). Importantly,
it is also unclear whether the proposed mechanism could be
cell-type-specific, as it has been shown that some cell lines
such as 3T3-L1 require MCE for terminal differentiation, whereas
other lines including a human preadipocyte line do not, even
though there is general consensus that mitosis checkpoint pro-
teins play an important role (Rosen and MacDougald, 2006).
Further investigation in other cell lines or even in vivo will be
required to validate the hypothesized role of the SMRT/KAISO
complex in terminal differentiation.
A final important observation is the fact that the loss of SMRT
results in the upregulation of proadipogenic genes, amongwhich
PPARg and C/EBPa are the most prominent, although this is not
sufficient for SMRT KD cells to spontaneously differentiate. This
observation leads to two important questions. First, why does
SMRT KD increase the expression of Pparg2 and C/ebpa?
One possible mechanism may be a direct release of repression
upon SMRT loss as there are two SMRT-binding sites within
the Pparg2 locus, of which one is also occupied by C/EBPb at
D0 and by other early adipogenic factors 4 hr after differentiation
induction. In addition, other adipogenic genes such as Ebf1 and
Akt1, which are known to activate PPARg (Jimenez et al., 2007;
Kim et al., 2010), are also upregulated in SMRTKD cells. Second,
why do SMRT KD cells not spontaneously differentiate? As
indicated, exposure of SMRT KD cells to the activating PPARg
ligand rosiglitazone is sufficient to induce terminal adipogenesis,
albeit to a lesser extent than cells exposed to complete dif-
ferentiation medium. This suggests that PPARg is not fully
transcriptionally active in SMRT KD cells, plausibly because
it is counteracted by antiadipogenic processes, of which the
upregulation of Wnt5a (next to, for example, Aspn, Trpv6, and348 Molecular Cell 46, 335–350, May 11, 2012 ª2012 Elsevier Inc.Tnfaip6) in SMRT KD cells could be one. WNT5a is known to
phosphorylate SETDB1, which results in the formation of a
SETDB1/CDH7 complex that represses PPARg (Takada et al.,
2007). Finally, it is worth noting that we also observed the
transcriptional and mRNA upregulation of important epithelial-
mesenchymal transition (EMT) genes such as Twist1 and Snai2
in SMRT KD cells. This may be important given the observation
that the induction of EMT endows cells with mesenchymal
stem cell properties (Battula et al., 2010), which has been
shown to enhance the efficiency of white fat cell differentiation
(Isenmann et al., 2009). Together, these findings suggest that
SMRT operates at the cross-section of several pro- and antiadi-
pogenic pathways, and that it therefore may have a critical role in
controlling the differentiation potential of 3T3-L1 cells by virtue of
its ability to integrate cell fate decisions. As such, it may function
as a more general gatekeeper of terminal differentiation.
It is clear that future work should now be focused on validating
these findings in other cell lines or even in vivo. In addition, it is
possible that some of our SMRT-related findings were muted
by the presence of the SMRT homolog NCoR1, as we found
that the majority of SMRT-bound DNA regions are also enriched
for NCoR1 binding. This suggests that SMRT andNCoR1may be
partially redundant and compensate for the absence of one
another, as has been proposed earlier (Perissi et al., 2010). It
will therefore be of interest in future studies to further dissect
the molecular context of the uncovered corepressor interactions
as well as their dynamic properties during terminal adipogenesis
and possibly to examine the involvement of other corepressors
in this process as well.
EXPERIMENTAL PROCEDURES
Cell Culture
3T3-L1 cells were cultured as detailed in Mikkelsen et al. (2010) with the only
difference that fetal calf serum was used instead of bovine calf serum (see
Supplemental Experimental Procedures for more details).
SMRT, NCoR1, and RNA pol II ChIP-Seq
At the indicated differentiation time points, the cells were fixed using 1% form-
aldehyde and stored at 80C. ChIP and Illumina sequencing was performed
as explained in Raghav and Deplancke (2012). Data handling and downstream
analyses are described in detail in the Supplemental Experimental Procedures.
ChIP for KAISO and H3K9me2
KAISO and H3K9me2 ChIP were performed as described by Reddy et al.
(2009) with slight modifications as detailed in the Supplemental Experimental
Procedures.
De Novo Motif Identification
The MEME software package was used to identify significant TF motifs in
SMRT-bound sequences, which were then compared against known motifs
using the TOMTOM motif comparison website (see Supplemental Experi-
mental Procedures for more details).
MITOMI-Based Analysis of KAISO-DNA Interactions
Putative KAISO DNA-binding sites derived from human KAISO and mouse
SMRT ChIP-Seq data were prepared for MITOMI analysis as explained in
detail in the Supplemental Experimental Procedures. The open-reading frame
of mouse KAISO was cloned using Gateway technology and transferred to
the pMARE vector as described in Hens et al. (2011) to enable the in vitro
expression of KAISO-eGFP fusion. MITOMI experiments were performed as
described previously (Maerkl and Quake, 2007).
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RNA pol II tags for SMRT peak-associated genes were counted and trans-
formed into the RPKM measure (Mortazavi et al., 2008) to compare the
transcriptional activity of genes at different days of differentiation (see
Supplemental Experimental Procedures for more details).
Stable Knockdown of SMRT, NCoR1, and KAISO
Lentivirus-mediated shRNA vectors were used to enable stable SMRT,
NCoR1, and KAISO protein knockdown in 3T3-L1 cells (see Supplemental
Experimental Procedures for more details).
ChIP-qPCR Validation
Random peaks for validation were selected from ChIP-Seq data. Wild-type,
SMRT, and KAISO KD stable 3T3-L1 cells were used to ChIP SMRT followed
by qPCR for selected genomic regions (for more method details, see
Supplemental Experimental Procedures).
RNA Isolation and qPCR for Gene Expression Analysis
Total RNA was isolated using an RNAeasy kit (QIAGEN). RT-qPCR was
performed using SuperScript III (Invitrogen), SYBR Green, and the 7900HT
Real-Time PCR system (Applied Biosystems). Primers were derived from
the GETPrime database (Gubelmann et al., 2011) and are listed in the
Supplemental Experimental Procedures.
Immunoprecipitation
SMRT andNCoR1 antibodieswere used to pull down KAISO from 3T3-L1wild-
type, shRNA control, KAISO KD, NCoR1 KD, and SMRT KD total cell lysates
followed by western blotting to confirm the presence of KAISO (see Supple-
mental Experimental Procedures for more details).
Cell Cycle Analysis
FACS analysis using propidium iodide was performed to analyze the cell-cycle
progression in SMRT KD, KAISO KD, and shRNA control 3T3-L1 cells (see
Supplemental Experimental Procedures for more details).
ACCESSION NUMBERS
SMRT, NCoR1, and RNA pol II ChIP-Seq data sets associated with this study
are available at ArrayExpress under the accession number E-MTAB-1031.
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